The Psychosocial Effects of Systemic / Family Constellation

February 18, 2021 updated by: Gergely Sándor Szabó, PhD, Károli Gáspár University of the Reformed Church in Hungary

The Psychosocial Effects of Systemic / Family Constellation: An Observational Follow-up Study

The purpose of this study is to investigate the psychosocial effects of systemic / family constellation. The method of systemic / family constellation refers to an approach which integrates ideas from family systems therapy with elements from psychodrama. The constellations are conducted in a group based seminar-setting, each seminar lasting two days.

Considering the very limited amount of empirical data on this method, the study design is a simple pre-post one with a 6-months follow-up. The study will be observational: the researchers will not manipulate who receives the intervention; instead they invite all clients (individuals from the general population) attending these therapeutic workshops run independently of the research process. Given the limited amount of evidence on this therapeutic method, special attention will be given to monitor potential adverse outcomes to establish intervention safety.

It is hypothesized that participation in a family constellation seminar might decrease potential psychological symptoms and will not result in adverse outcomes.

Study Overview

Study Type

Observational

Enrollment (Actual)

182

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Budapest, Hungary, 1037
        • Károli Gáspár University of the Reformed Church in Hungary

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals from the general population who seek help through family constellation seminars for various mild to moderate psychological symptoms.

Description

Inclusion Criteria:

  • Self-referred and registered for a family constellation workshop with one of the therapists (clinical psychologist / psychiatrist) who were willing to collaborate with the researchers of the present study

Exclusion Criteria:

  • Age under 18 years
  • Currently suffers from a diagnosed mental disorder
  • Participated actively (not merely as a "representative") in a family constellation intervention in the 12 months preceding baseline assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Workshop participants
Participants of systemic / family constellation workshops
Systemic / family constellation integrates elements from psychodrama, family sculpture, and spontaneous dramatizations of intra- and interpersonal processes, while spatially visualizing family dynamics. Family constellations stimulate change through the following ways: 1) making visible the spatial arrangement of relationships within a conflictual system; 2) providing access to the insights of unrelated third parties regarding the sensations, feelings, and thoughts they experienced while representing family members within the constellation; and 3) making observable (from the outside) and experienceable (from within) the transformation of the problem constellation into the solution constellation [Hunger, Weinhold, Bornhäuser, Link, & Schweitzer, 2015].

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in scores on the Brief Symptom Inventory
Time Frame: Before, 1 month after and 6 months after the intervention
A broad spectrum of psychopathological symptoms including somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism
Before, 1 month after and 6 months after the intervention
Change in answers to ad hoc items developed for qualitative analysis
Time Frame: 1 and 6 months after the intervention
These items are developed by the study authors to 1) screen for any potential adverse outcomes as a result of the intervention, 2) better understand the treatment goals of individuals participating in this form of therapy and how these relate to what they perceive as the outcome of the intervention
1 and 6 months after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in scores on the Experience in Personal Social Systems Questionnaire
Time Frame: Before, 1 month after and 6 months after the intervention
Assessment of how the members of a personal social system experience their situation within that system.
Before, 1 month after and 6 months after the intervention
Change in scores on the Patient Health Questionnaire Somatic Symptom Severity Scale (PHQ-15)
Time Frame: Before, 1 month after and 6 months after the intervention
The PHQ-15 includes 15 somatic symptoms (headache, stomach pain, chest pain, dizziness, etc.) that account for more than 90% of symptoms seen in primary care (exclusive of upper respiratory symptoms)
Before, 1 month after and 6 months after the intervention
Change in scores on the SCOFF
Time Frame: Before, 1 month after and 6 months after the intervention
The SCOFF is a brief screener to detect increased risk for eating disorders
Before, 1 month after and 6 months after the intervention
Change in scores on ad hoc items to assess behavioral and substance-related addictions
Time Frame: Before, 1 month after and 6 months after the intervention
Items assess perceived problem severity with addictions
Before, 1 month after and 6 months after the intervention
Change in scores on the Meaning in Life Questionnaire (MLQ)
Time Frame: Before, 1 month after and 6 months after the intervention
The MLQ assesses the perceived level of the presence and search for meaning in an individual's life
Before, 1 month after and 6 months after the intervention
Change in scores on the World Health Organization Wellbeing Index (WBI-5)
Time Frame: Before, 1 month after and 6 months after the intervention
The WBI-5 captures the general well-being of the individuals
Before, 1 month after and 6 months after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Barna Konkoly Thege, PhD, Department of Psychiatry, Univeristy of Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

October 30, 2020

Study Completion (Actual)

October 30, 2020

Study Registration Dates

First Submitted

July 25, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (Actual)

July 31, 2017

Study Record Updates

Last Update Posted (Actual)

February 21, 2021

Last Update Submitted That Met QC Criteria

February 18, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 325/2017/P

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The investigators have not requested permission from their study participants to make their data available to others to increase participants' sense of confidentiality and so willingness to participate in the study. As a consequence, in case of a data sharing request, the investigators would have to seek for additional explicit permission from the participants. As the investigators have committed to destroy participant contact data after finishing the study, the chances of such data sharing seem slim. However, the investigators are more than happy to conduct alternative analyses based on interested colleagues' suggestions / inquiry and share the raw output (including analytic syntax) of such analyses with those making the inquiry.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild to Moderate Psychopathological Symptoms

Clinical Trials on Systemic / family constellation

3
Subscribe